secwatch.observer — SEC 8-K summary
======================================

Issuer:     OPKO HEALTH, INC. (OPK)
CIK:        0000944809
Form:       8-K
Filed at:   2022-08-16T23:59:59+00:00
Accession:  0000944809-22-000043
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OPKO Health’s Senior VP and BioReference CEO Jon R. Cohen retires; receives $1M severance
--------------------------------------------------------------------------------

- Dr. Jon R. Cohen retired as SVP of OPKO, Executive Chairman & CEO of BioReference, and board member effective Aug 16, 2022.
- He will serve as advisor through Dec 31, 2022, then consultant through Aug 2023.
- Severance includes $1,000,000 aggregate and full vesting acceleration of all unvested stock options as of Dec 31, 2022.
- Retirement not due to any disagreement with the company on operations, policies, or practices.
- Severance agreement includes confidentiality, non-solicitation, non-disparagement, and cooperation clauses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/944809/000094480922000043/0000944809-22-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/944809/000094480922000043/opk-20220816.htm
  HTML page:      https://secwatch.observer/filing/0000944809-22-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer